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ABSTRACT The key player in directing proper chromosome segregation is the macromolecu-
lar kinetochore complex, which mediates DNA–microtubule interactions. Previous studies 
testing individual kinetochore genes documented examples of their overexpression in tu-
mors relative to normal tissue, leading to proposals that up-regulation of specific kinetochore 
genes may promote tumor progression. However, kinetochore components do not function 
in isolation, and previous studies did not comprehensively compare the expression behavior 
of kinetochore components. Here we analyze the expression behavior of the full range of 
human kinetochore components in diverse published expression compendia, including nor-
mal tissues and tumor samples. Our results demonstrate that kinetochore genes are rarely 
overexpressed individually. Instead, we find that core kinetochore genes are coordinately 
regulated with other cell division genes under virtually all conditions. This expression pattern 
is strongly correlated with the expression of the forkhead transcription factor FoxM1, which 
binds to the majority of cell division promoters. These observations suggest that kinetochore 
gene up-regulation in cancer reflects a general activation of the cell division program and that 
altered expression of individual kinetochore genes is unlikely to play a causal role in tumori-
genesis.
INTRODUCTION
Proper chromosome segregation during mitosis is central to 
maintaining genome integrity. Even subtle chromosome segre-
gation defects result in inappropriate chromosome numbers 
(termed aneuploidy), which are observed in >70% of tumors and 
have been suggested to promote tumorigenesis (Holland and 
Cleveland, 2009). Thus it is critical to understand the perturba-
tions that contribute to chromosome missegregation during 
tumorigenesis. Proper chromosome segregation requires the 
multiprotein kinetochore complex, which connects chromosomal 
DNA to spindle microtubule polymers to provide the structure 
and forces required to align and segregate the replicated sister 
chromatids (Cheeseman and Desai, 2008). Because most kineto-
chore proteins exist in multisubunit complexes, increased ex-
pression of an individual kinetochore gene could cause subunit 
imbalances and create dominant-negative defects that disrupt 
high-fidelity chromosome segregation. Indeed, previous studies 
reported multiple examples of individual kinetochore genes that 
are up-regulated in tumor samples relative to normal tissue con-
trols. This includes the kinetochore-localized microtubule-bind-
ing protein Ndc80/highly expressed in cancer 1 (Hec1; Chen 
et al., 1997; Hayama et al., 2006), the spindle assembly check-
point proteins Mad1 (Ryan et al., 2012), Mad2 (Sotillo et al., 
2007), and Bub1 (Shigeishi et al., 2001; Grabsch et al., 2003), 
regulatory components, including Cdc20 (Mondal et al., 2007) 
and Aurora B (Bischoff et al., 1998; Vischioni et al., 2006), and 
key structural kinetochore proteins, including KNL1/CASC5 
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Kinetochore genes display coordinated expression 
in normal tissues
We first assessed the expression of our selected genes in normal 
tissue samples using data from the Human Body Index (HBI; GEO 
Accession No. GSE7307; www.ncbi.nlm.nih.gov/geo). We normal-
ized the expression of each gene relative to its median expression 
level across the entire set of samples and plotted these data as a 
heat map to indicate the level of up-regulation or down-regulation 
relative to this median expression (Figure 1). In this analysis, the 
mRNA levels of the Core Kinetochore genes were positively corre-
lated (correlation of 0.44), representing coordinate expression across 
the entire selection of tissue samples. The highest levels of expres-
sion for these genes were observed in testes, bone marrow, and 
other tissues believed to show higher overall levels of cell division. 
Core Kinetochore components were expressed at lower levels in 
terminally differentiated tissues, including brain and neuronal sam-
ples. In this analysis, our selected Cell Cycle/DNA Replication genes 
displayed similar expression profiles to Core Kinetochore genes 
across these diverse samples. In contrast, as expected based on the 
role of the cytoplasmic dynein motor in axonal transport, we found 
that some Multifunctional Kinetochore genes, including dynein and 
its multiple associated proteins, were up-regulated in brain and neu-
ronal samples. On the basis of the multiple cellular functions for 
these Multifunctional Kinetochore proteins, as well as their distinct 
and diverse behaviors in the data sets analyzed later (unpublished 
data), for simplicity we excluded these genes from subsequent 
figures. This analysis indicates that the selected Core Kinetochore 
and cell division genes are coordinately expressed across noncan-
cerous human tissue samples.
Cell cycle expression of kinetochore genes
In the human tissue samples analyzed, Core Kinetochore gene ex-
pression appeared to correlate with the presumptive cell division 
frequency (mitotic index) of a given tissue. If these genes are up-
regulated during the mitotic phase of the cell cycle, the increased 
expression observed in these samples could be due to an increased 
proportion of mitotic cells. Similarly, if Cell Cycle genes are ex-
pressed in a specific cell cycle stage, their increased expression in 
frequently dividing tissues could be due to increased occupancy of 
that cell cycle stage. Therefore we sought to assess the relationship 
between the expression of these genes and cell cycle stage. To test 
the relationship between Core Kinetochore gene expression and 
cell cycle progression, we analyzed periodic gene expression in a 
data set that analyzed time points in synchronously dividing human 
cells (Grant et al., 2013). We found that a subset of Core Kineto-
chore genes was periodically expressed during the cell cycle (Figure 
2). These periodically expressed genes are enriched for outer kine-
tochore proteins and regulatory components that localize to kineto-
chores only during mitosis. However, the majority of Core Kineto-
chore genes and other cell division components did not show 
dramatic differences in their expression behavior during the cell cy-
cle (Figure 2). This suggests that the up-regulation of Core Kineto-
chore and Cell Cycle genes observed in frequently dividing normal 
tissues represents a general activation of the cell division program 
rather than expression due to increased occupancy of a specific cell 
cycle stage.
Kinetochore genes are up-regulated in tumors
Multiple studies demonstrated that individual kinetochore genes 
are up-regulated in tumors relative to normal tissue controls 
(see Introduction). To test whether this up-regulation is broadly 
true for other Core Kinetochore and Cell Cycle/DNA Replication 
(Takimoto et al., 2002), CENP-A (Tomonaga et al., 2003), CENP-
H (Tomonaga et al., 2005; Shigeishi et al., 2006), and many 
others.
The observations that selected kinetochore genes are up-regu-
lated in tumors has led to proposals that this up-regulation may act 
as a causal event for tumor initiation or progression (Yuen et al., 
2005). In a subset of cases, this hypothesis has been tested using 
mouse models in which the expression of a given kinetochore gene 
is artificially up-regulated. Strikingly, up-regulation of Mad2 (Sotillo 
et al., 2007), Ndc80/Hec1 (Diaz-Rodriguez et al., 2008), or Aurora B 
(Ricke et al., 2011) can increase the incidence of cancer formation in 
mice. Although these studies demonstrate that up-regulation of a 
kinetochore gene has the potential to promote tumorigenesis, the 
physiological relevance of these up-regulation events in human tu-
mors remains unclear.
Here we seek to evaluate comprehensively kinetochore gene 
expression in diverse, publicly available data sets to determine 
the relative expression behavior of kinetochore genes. Our re-
sults demonstrate that core kinetochore genes are coordinately 
expressed under all analyzed conditions, including in normal 
human tissues, tumors, and cancer cell lines. In addition, kineto-
chore genes show similar expression behavior to other cell divi-
sion genes. Most kinetochore genes do not display strong 
periodic mitosis-specific expression during the cell cycle, indicat-
ing that the observed up-regulation is not due solely to an 
increased proportion of mitotic cells in tumors. Instead, this 
expression behavior appears to reflect the induction of a broad 
but specific cell division program. To define key upstream factors 
involved in the induction of this cell division program, we analyze 
the relationship between kinetochore gene expression and estab-
lished transcription factors. Our data suggest that this expression 
program is closely related to the behavior of the forkhead-family 
transcription factor, FoxM1. Thus kinetochore genes in tumors are 
coordinately expressed as part of a general activation of the cell 
division program that appears to function downstream of 
FoxM1.
RESULTS
Selection of kinetochore and cell division genes 
for expression analysis
To analyze the relative expression of kinetochore genes, we first 
generated a list of genes that could be used to assess expression 
profiles across diverse cell types. Work from our laboratory and 
many others has identified >100 different kinetochore-localized 
proteins in human cells (Cheeseman and Desai, 2008). These ki-
netochore proteins can be grouped into two broad functional cat-
egories: 1) core kinetochore proteins, which function exclusively 
at kinetochores; and 2) multifunctional kinetochore proteins, 
which function at kinetochores and additional subcellular loca-
tions (e.g., the microtubule-based motor cytoplasmic dynein or 
the nucleoporin Nup107-160 complex). To analyze the expression 
of other key genes required for dividing cells, we also selected 
genes involved in DNA replication and cell cycle regulation. Fi-
nally, to provide a comparison to both normal cellular processes 
and cancer states, we selected several representative housekeep-
ing genes and genes whose up-regulation has been implicated in 
tumor progression (e.g., Myc and Ras). In total, we defined five 
functional categories that we refer to as follows: Core Kineto-
chore, Multifunctional Kinetochore, Cell Cycle/DNA Replication, 
Housekeeping, and Cancer Up-regulated. The selected genes 
and the corresponding categories are given in Supplemental 
Table S1.
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relative expression of our selected genes in the Broad Cancer Cell 
Line Encyclopedia (Figure 4), which contains expression data for 991 
cancer cell lines (www.broadinstitute.org/ccle; Barretina et al., 2012), 
and the Expression Project for Oncology (expO) data set (Figure 5), 
which contains 2158 tumor samples (GEO Accession No. GSE2109). 
For these analyses, we first defined the median expression level for 
a given gene across all of the samples in a data set. We then com-
pared its expression level in each sample to that median expression 
level to define the relative level of up- or down-regulation. This nor-
malized expression level for a given gene across the diverse samples 
allowed us to evaluate the variation in gene expression among tu-
mor populations. Based on this methodology, half of the samples 
should display reduced expression relative to this median level. 
However, based on the analysis of the matched TCGA breast cancer 
samples (Figure 3), each kinetochore gene is likely to be up-regu-
lated relative to normal tissue.
Our analysis of gene expression behavior in tumor and cancer 
samples demonstrated that there is a strong similarity between 
changes in the mRNA levels of the Core Kinetochore components 
and Cell Cycle/DNA Replication genes (Figures 4 and 5). This 
expression profile was distinct from the other classes of genes 
components, we analyzed their gene expression in The Cancer 
Genome Atlas (TCGA) study of breast cancer (Cancer Genome 
Atlas Network, 2012), in which matched breast tumor samples and 
normal tissue controls were analyzed for 28 different patients 
(Figure 3). For this analysis, gene expression in each individual 
tumor sample was normalized relative to the level of gene expres-
sion in the corresponding matched normal tissue sample. In this 
analysis, half of the Core Kinetochore and Cell Cycle/DNA Replica-
tion genes (36 of 71 genes) were significantly up-regulated (false 
discovery rate p < 0.05 and at least twofold change, t test) in the 
tumor samples relative to the normal tissue controls. These data 
suggest that tumors broadly activate genes required for cell divi-
sion rather than up-regulate individual cell division genes.
Kinetochore genes are coordinately regulated in diverse 
tumor and cancer samples
The matched tumor/normal tissue samples provide an important 
comparison for evaluating the up-regulation of kinetochore genes. 
However, these paired experiments are of limited sample size, pre-
venting an extensive analysis of the coordinated behavior of kineto-
chore genes across different conditions. Therefore we analyzed the 
FIGURE 1: Kinetochore gene expression across normal human tissues. Gene expression data were obtained from the 
HBI (GEO Accession No. GSE7307). Selected genes were median centered, with changes in expression level color 
coded as indicated. Multiple samples within a given tissue category (e.g., Brain) were grouped and clustered. To the left 
of the expression data, a hierarchical clustering tree indicates the relationship between genes based on expression 
patterns. To the right of the expression data, genes are classified based on their functional category.
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expression of Mad1 (Mad1L1) and p31/Comet (Mad2L1BP) in skin 
cancer cell lines from the CCLE data set (Figure 4). Therefore most 
individual kinetochore genes are not up-regulated in isolation, but 
instead their expression represents the broad induction of Core 
Kinetochore and Cell Cycle genes.
Although we found that Core Kinetochore genes generally be-
haved similarly to each other, as a group they exhibited variation 
in mRNA levels across the different tumors and cancer cell lines. 
included in our analysis, including Housekeeping genes and classi-
cally defined Cancer Up-regulated genes. In contrast to previous 
proposals, Core Kinetochore genes are not differentially expressed 
but are instead largely coordinately expressed across diverse tumors 
and cancers. In fact, we observed only a few, rare cases in which an 
analyzed Core Kinetochore gene showed clearly uncoordinated ex-
pression behavior. This includes increased expression of CENP-N in 
prostate tumors in the expO data set (Figure 5) and increased 
FIGURE 2: Kinetochore gene expression throughout the cell cycle. Gene expression data were obtained from Grant 
et al. (2013), who analyzed synchronous cell cycles in U20S cells blocked and released with the time points as indicated 
(top). Selected genes were displayed relative to the reference expression level, with changes in expression level color 
coded as indicated. To the right of the expression data, genes are classified based on their functional category. 
Periodically expressed genes are clustered at the top as indicated. Arrows indicate approximate mitotic times based on 
cell synchronization (Grant et al., 2013).
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behavior in those tumors in the expO data set from patients who 
smoked relative to nonsmokers (unpublished data). In addition, 
we did not detect differences in the sensitivity of the cell lines from 
the CCLE data set to antimitotic drugs, including Taxol, based on 
the varying Core Kinetochore gene expression levels (unpublished 
data).
We therefore sought to determine whether this relative expression 
behavior correlated with different tumor properties or behaviors. 
We did not detect an obvious correlation between the level of 
Core Kinetochore gene expression and the pathological stage of 
the tumor in the expO tumor data (unpublished data). Similarly, 
we did not observe any noticeable difference in the expression 
FIGURE 3: Kinetochore gene expression in tumors vs. normal tissue. Gene expression data were obtained from the 
TCGA study of invasive breast cancer (Cancer Genome Atlas Network, 2012). Expression levels of the selected genes in 
tumor samples were compared with the expression levels in the corresponding matched normal tissue control, with 
changes in expression level color coded as indicated. To the left of the expression data, a hierarchical tree indicates the 
relationship between expression patterns. To the right of the expression data, genes are classified based on their 
functional category.
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compared the expO tumor expression data to the tissue-specific 
expression levels from the HBI. Based on this comparison, the ex-
pression of Core Kinetochore genes is up-regulated to a roughly 
similar extent in these diverse tumor samples relative to the corre-
sponding tissue of origin (Figure 6). Thus these differing expression 
levels primarily reflect the basal state of the starting tissue rather 
than a specific feature of tumorigenesis in a given tissue.
In contrast, we observed a clear relationship between the mRNA 
level and the identity of the tissue from which the tumor or cell line 
was derived. For example, much higher levels of Core Kinetochore 
and Cell Cycle/DNA Replication genes were observed in colon, cer-
vix, and uterus samples, with lower relative levels present in kidney, 
prostate, and thyroid samples (Figures 4 and 5). Because matched 
normal/tumor samples are not available in the expO data set, we 
FIGURE 4: Kinetochore gene expression in cancer cell lines. Gene expression data were obtained from the CCLE 
(Barretina et al., 2012). Selected genes were median centered, partitioned into groups by tissue of origin (as shown 
across the top), and clustered within that group, with changes in expression level color coded as indicated. To the left of 
the expression data, a hierarchical tree indicates the relationship between expression patterns. To the right of the 
expression data, genes are classified based on their functional category.
 SPDL1 
 MIS12 
 ZW10 
 SKA2 
 MIS18BP1 
 RAD21 
 SMC3 
 CENPN 
 CENPH 
 SKA1 
 CENPQ 
 CENPK 
 SMC2 
 CENPI 
 CENPO 
 ZWILCH 
 KNSTRN 
 CENPL 
 CENPF 
 NUF2 
 NEK2 
 CASC5 
 CENPE 
 SGOL2 
 CENPW 
 NDC80 
 TTK 
 OIP5 
 BUB1B 
 CENPA 
 CCNB2 
 SPC25 
 MAD2L1 
 CCNA2 
 PLK4 
 ZWINT 
 CDK1 
 SPAG5 
 BIRC5 
 HJURP 
 BUB1 
 KIF2C 
 CDCA8 
 AURKB 
 PLK1 
 CDC20 
 PTTG1 
 AURKA 
 CCNB1 
 NCAPD2 
 FOXM1 
 ITGB3BP 
 MLF1IP 
 GSG2 
 SKA3 
 INCENP 
 NCAPD3 
 KNTC1 
 CDC7 
 ESPL1 
 MIS18A 
 CENPM 
 CDC45 
 GINS2 
 MCM2  
 CDT1 
 ORC1 
 ORC6 
 GINS3 
 PCNA 
 GINS1 
 SGOL1 
 DBF4 
 DSN1 
 E2F1 
 CDC6 
 MASTL 
 HSP90AA1 
 PSMB1 
 PMF1 
 RPL38 
 BUB3 
 NSL1 
 CENPC1 
 MDM4  
 GABPA 
 BCL2 
 TERT 
 MDM2  
 HIST1H3A 
 PIK3CA 
 CDC34 
 AKT2 
 CCNE1 
 KRAS 
 MYC 
 REL 
 FOXO1 
 MAD1L1 
 MAD2L1BP 
 GAPDH 
 MITF 
 CENPT 
 E2F4 
 ACTB 
 FOXC2 
 FOXP3 
 CCNA1 
 MYCL1 
 NKX2-1 
 SOX2 
 MYCN 
 ALK 
 LMO1 
 EGFR 
 JUN 
 ERBB2 
 ERBB3 
 FOXA1 
 FOXO3 
 -2 
 -1 
 0 
 1 
 2 
 3 
 -3 
Median
log2 Ratio
Gene Classification
Cancer Upregulated
Cell Cycle / DNA Replication
Core Kinetochore
House Keeping
Ha
em
ato
po
iet
ic 
an
d
 
 
 
 
lym
ph
oid
 tis
su
e
Sk
in
Ce
ntr
al 
ne
rvo
us
 
 
 
 
sy
ste
m
Lu
ng
Ot
he
r
Ov
ary
Up
pe
r a
ero
dig
es
tiv
e 
 
 
 
 
tra
ct
Br
ea
st
Pa
nc
re
as
St
om
ac
h
Cancer Cell Line Encyclopedia (CCLE)
Volume 25 July 1, 2014 Cancer kinetochore gene expression | 1989 
observed highly correlated expression profiles for kinetochore 
genes in the CCLE cancer cell line data and expO tumor data set 
(Figure 7).
We also sought to analyze the expression of specific kinetochore 
protein complexes for which up-regulation in cancers has been re-
ported previously. Ndc80/Hec1 assembles as part of a four-subunit 
Ndc80 complex that includes Nuf2, Spc24, and Spc25. Ndc80/Hec1 
has been shown to be up-regulated in tumors (Chen et al., 1997; 
Hayama et al., 2006), and mice overexpressing Ndc80 display in-
creased cancer formation (Diaz-Rodriguez et al., 2008). If the Ndc80 
Kinetochore protein interaction partners display closely 
coordinated expression
The similar expression behavior observed in tumors and cancer cell 
lines for the Core Kinetochore genes has important implications for 
the consequences of this altered expression. Because most kineto-
chore proteins exist in multisubunit protein complexes, the relative 
protein levels of the different subunits, rather than the precise 
amounts of a given subunit, will affect the behavior of that complex. 
Therefore we sought to analyze the statistical correlation for the 
gene expression behaviors of Core Kinetochore genes. Overall we 
FIGURE 5: Kinetochore gene expression in tumors. Gene expression data were obtained from the expO (GEO 
Accession No. GSE2109). Selected genes were median centered, partitioned into groups by tissue of origin (as shown 
across the top), and clustered within that group, with changes in expression level color coded as indicated. To the left of 
the expression data, a hierarchical tree indicates the relationship between expression patterns. To the right of the 
expression data, genes are classified based on their functional category. To the far right, the bar graph indicates the 
relative fold enrichment of FoxM1 binding to the promoter of each gene based on ChIP-seq data (from ENCODE 
Project Consortium et al., 2012).
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FIGURE 6: Tumor gene expression normalized relative to corresponding normal tissue. Gene expression data from the 
expO tumor data set were compared with the median expression in the corresponding normal tissue from the HBI data 
set. For example, kidney tumors were compared with the median expression in normal kidney tissues. These data 
suggest that tumors display similar degrees of up-regulated expression of kinetochore genes. To the left of the 
expression data, a hierarchical tree indicates the relationship between expression patterns. To the right of the 
expression data, genes are classified based on their functional category.
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2013). Our analysis of the tumor and cell line expression data 
revealed that Mad2 and Cdc20 displayed highly coordinated gene 
expression across the diverse samples (correlation of 0.43 in the 
CCLE data and 0.85 in the expO data).
Finally, we tested the correlation between the subunits of the 
Mis12 complex. Mis12 complex subunits (Mis12, Dsn1, Nnf1/Pmf1, 
and Nsl1) form an integrally associated, stable subcomplex (Kline 
et al., 2006) but have not been a focus of previous studies on kine-
tochore gene up-regulation in cancer. Although Mis12 complex 
subunits show similar expression to other kinetochore genes in our 
analyses, the four subunits of this complex are not as strongly cor-
related as the Ndc80 complex (0.26 in the CCLE data set and 0.16 
in the expO data sets). However, previous work on the Mis12 com-
plex found that the protein levels of the Mis12 complex subunits are 
very sensitive to each other. For example, Dsn1 appears to be very 
unstable in the absence of the other subunits, both in cells (Kline 
et al., 2006) and in biochemical reconstitution experiments 
(Cheeseman et al., 2006). Although we focused here on the tran-
scriptional control of kinetochore gene expression, translational and 
posttranslational control of protein levels will also affect the final 
subunit balances present in the cell.
protein were specifically up-regulated in the absence of its binding 
partners, this would cause severe defects with the potential for 
dominant-negative consequences to the fidelity of chromosome 
segregation. In contrast, coordinate mRNA up-regulation of the 
Ndc80 complex subunits would avoid defects due to unbalanced 
subunit components. On the basis of our analysis, we found similar 
expression behavior for Ndc80, Nuf2, and Spc25 in cancer cell lines 
and tumors (correlation of 0.64 in CCLE data and 0.78 in expO data; 
the Spc24 probeset was unavailable for this analysis).
Similarly, previous work implicated overexpression of the spindle 
assembly checkpoint protein Mad2 (MAD2L1) as a potential causal 
factor in promoting tumorigenesis (Sotillo et al., 2007). Although ar-
tificial overexpression of Mad2 can induce tumor formation in mice 
(Sotillo et al., 2007), it is unclear whether such up-regulation of Mad2 
alone occurs in human tumors. Cells are exquisitely sensitive to the 
level of Mad2, with subtle changes in concentration altering spindle 
assembly checkpoint signaling and mitotic progression (Heinrich 
et al., 2013). However, the absolute level of Mad2 in a cell does not 
appear to be the primary factor controlling checkpoint function. In-
stead, the level of Mad2 relative to its binding partner and down-
stream target Cdc20 is the key, determining factor (Heinrich et al., 
FIGURE 7: Correlations for kinetochore gene expression data from the CCLE and expO data sets. To assess the 
correlations in the gene expression profiles of the kinetochore genes (as well as the FoxM1 and E2F1 transcription 
factors), pairwise comparisons between the expression profiles for each pair of genes were tested in the CCLE and 
expO data sets. To the left of the expression data, a hierarchical tree indicates the relationship between gene 
correlations. Overall kinetochore genes display highly correlated gene expression profiles in tumors and cancer cell 
lines.
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expression of a transcription factor would be likely to affect the 
behavior of multiple downstream genes. Second, a promoter or 
enhancer region of an individual gene could be altered to increase 
the level of transcription. Third, the copy number of the gene could 
be increased through amplification or other genomic changes. 
However, because large genomic regions are typically amplified in 
cancers, it can be hard to assess which individual gene(s) within this 
amplified region are responsible for tumor behavior.
In cases in which a kinetochore gene is amplified or its promoter 
region is altered, this would be predicted to affect the mRNA level 
of that gene but not other kinetochore components. Such cases 
could represent causal events in tumor progression, as they could 
disrupt subunit balances within the macromolecular kinetochore 
structure and result in dominant-negative defects in kinetochore 
function, compromising the fidelity of chromosome segregation. 
However, it was unclear whether up-regulation of individual kineto-
chore genes occurs in human tumors. Here we analyzed kinetochore 
gene expression in diverse, publicly available expression compen-
dia, which revealed that kinetochore genes are largely coordinately 
expressed across diverse conditions. On the basis of this strongly 
correlated behavior, we conclude that the up-regulation of an indi-
vidual kinetochore gene is unlikely to be a causal factor in the vast 
majority of human cancers. However, we cannot exclude the possi-
bility that minor changes in gene expression (less than twofold) do 
occur for some kinetochore components. Based on recent analysis 
in fission yeast (Heinrich et al., 2013), such subtle imbalances for 
some kinetochore components could result in changes in mitotic 
progression or fidelity. We note that detecting such subtle changes 
in expression would be beyond the sensitivity of most experimental 
approaches, and experiments testing the consequences of artifi-
cially up-regulating kinetochore genes have induced >10-fold over-
expression of a selected component.
Instead of specifically up-regulating specific kinetochore compo-
nents, cancers appear to activate a broad-based cell division pro-
gram that involves both the core kinetochore components and other 
genes required for cell cycle progression and DNA replication. We 
propose that this is not strictly related to mitotic index or doubling 
time of the cancer cells. Indeed, most kinetochore genes are not 
strongly periodically expressed during the cell cycle. Instead, this ap-
pears to be a general activation of the cell division program. Previous 
work found similar gene clusters for genes that function in related 
processes, such as ribosomal or proteasomal components (Niehrs 
and Pollet, 1999). On the basis of the observed coexpression behav-
ior of the FoxM1 transcription factor and the binding of FoxM1 to the 
promoters of cell division genes, we propose that the up-regulation 
of the cell division program occurs downstream of FoxM1. Activation 
of this cell division program may allow a cell to be poised for cell divi-
sion such that these proteins are ready to facilitate mitosis once 
additional cues signal cell cycle entry.
Our analyses provide an important context for considering the 
roles of kinetochore components in driving tumor progression 
and highlight the general activation of the cell division program in 
tumors. Because many cancer cells have been shown to display 
error-prone chromosome segregation (chromosomal instability; 
Thompson et al., 2010), it is important to define the molecular 
basis for this behavior. Our analysis suggests that dramatic changes 
in the expression of an individual kinetochore gene are unlikely to 
be responsible for chromosome instability. In contrast, the recent 
sequencing of cancer cell (Barretina et al., 2012) genomes revealed 
widespread mutations in components of the kinetochore and cell 
division apparatus that represent interesting candidates for future 
analyses.
Overall our analyses indicate that despite previous reports, Mad2 
and Ndc80/Hec1 do not appear to be specifically up-regulated in 
cancer and tumor samples and instead are expressed as part of a 
larger cluster containing the Core Kinetochore and Cell Cycle/DNA 
Replication genes.
Expression of the FoxM1 transcription factor is highly 
correlated with expression of cell division genes
The coordinated expression of the Core Kinetochore and Cell Cy-
cle/DNA Replication genes across the diverse data sets that we ana-
lyzed suggests that there is a transcriptional basis for this similar 
expression. To evaluate this, we analyzed the expression of genes 
that have been shown to control key gene expression programs, 
including the forkhead-type transcription factors and the prolifera-
tion promoting transcription factors E2F1 and E2F4.
E2F1 displayed moderately correlated gene expression to Core 
Kinetochore components in the CCLE and expO tumor data sets 
(correlations of 0.38 and 0.26, respectively). However, the E2F4 tran-
scription factor did not show similar expression to kinetochore com-
ponents (correlation −0.09). This is consistent with our observations 
that the expression behavior of the cell division genes is not strictly 
related to increased expression of periodically expressed genes, 
many of which are regulated downstream of E2F (Ren et al., 2002).
The majority of forkhead-family transcription factors (including 
FoxA1, FoxC2, FoxO1, FoxO3, and FoxP3) did not display detect-
able similarity to the expression of the Core Kinetochore genes and 
Cell Cycle/DNA Replication components. In contrast, we found that 
FoxM1 showed highly correlated expression to kinetochore compo-
nents in the expO tumor data (Figure 7; correlation 0.65). FoxM1 
binds to promoter regions of the majority of kinetochore genes and 
cell division components based on recent chromatin immunopre-
cipitation followed by high-throughput DNA sequencing (ChIP-seq) 
analyses (Figure 5; ENCODE Project Consortium et al., 2012 ; Chen 
et al., 2013; Grant et al., 2013; Sanders et al., 2013). In particular, 
FoxM1 displays at least 10-fold enrichment of its ChIP-seq signal 
compared with a control IP in a region encompassing 1 kb upstream 
and 100 base pairs downstream of the transcriptional start site for 
48 of 56 Core Kinetochore genes. This suggests that FoxM1 contrib-
utes to the coordinated expression of Core Kinetochore and Cell 
Cycle genes observed in normal tissues and cancer samples. In-
deed, previous work found that FoxM1 is required for cell cycle pro-
gression and expression of multiple cell division genes (Laoukili 
et al., 2005; Grant et al., 2013). Coordinated expression of FoxM1-
dependent genes suggests that regulation of FoxM1 itself could be 
a fundamental step in activating the cell division expression pro-
gram in normal tissues and cancers.
DISCUSSION
Previous work documented numerous cases in which a given kineto-
chore gene is overexpressed in a selection of tumors. These obser-
vations led to proposals that such overexpression could be a causal 
event in promoting tumorigenesis (Yuen et al., 2005). In fact, recent 
work shows that artificially up-regulating individual kinetochore 
genes can promote tumor formation in mice (Sotillo et al., 2007; 
Diaz-Rodriguez et al., 2008; Ricke et al., 2011), but a broad-based 
consideration of whether such up-regulation of individual genes oc-
curs in human tumors has been lacking.
To evaluate the significance of observed gene up-regulation in 
cancer, defining the basis for this up-regulation is of critical impor-
tance. There are several mechanisms by which a gene could be up-
regulated. First, the expression of its corresponding upstream tran-
scription factors could be changed. In this case, the altered 
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For TCGA breast invasive carcinoma data, processed Agilent ex-
pression data (level 3) for matching normal and tumor pairs (sample 
IDs are given in Table 1) were downloaded from the TCGA data 
portal (https://tcga-data.nci.nih.gov). For each cancer sample, log2 
ratios of selected genes were calculated relative to the matching 
normal sample, and the heatmap was created as described.
A subset of the expO tumor samples was also compared with 
normal counterparts in the HBI compendium. For each of the com-
mon HBI tissues (kidney, colon, liver, breast, lung, ovary/uterus, and 
prostate), the median expression level of each gene in that tissue 
was calculated, and each expO tumor sample was compared with 
the set of corresponding normal medians. The heatmap was gener-
ated as described.
Pearson correlations were calculated in R by comparing the ex-
pression (log2 ratios) of each gene against every other gene in the 
data set. The correlation values were then clustered in Cluster3 and 
visualized in Java TreeView, as described. Correlations were sum-
marized by the mean via Fisher transformation.
FOXM1 ChIP-Seq peaks were downloaded from the ENCODE 
project (https://genome.ucsc.edu/ENCODE/downloads.html, under 
MATERIALS AND METHODS
Data processing and analysis
For each expression compendium (HBI [GEO Accession No. 
GSE7307], expO [GEO Accession No. GSE2109], and CCLE [www 
.broadinstitute.org/ccle]), Affymetrix Human Genome U133 Plus 2.0 
arrays were normalized with robust multiarray average (RMA) using 
the affy package from Bioconductor (www.bioconductor.org/ 
packages/release/bioc/html/affy.html) and Entrez Gene (www.ncbi 
.nlm.nih.gov/gene) ID custom probeset definitions as defined previ-
ously (Dai et al., 2005). The RMA values of selected genes were sub-
sequently median centered and hierarchically clustered (based on 
uncentered correlation and average linkage) using Cluster 3.0 
(de Hoon et al., 2004) and visualized with Java TreeView (Saldanha, 
2004). Principal component analysis plots gave similar results to the 
hierarchical clustering (unpublished data).
For the cell cycle study (Grant et al., 2013), processed Agilent 
Whole Human Genome Oligonucleotide array ratios (sample/refer-
ence) were downloaded from Supplemental Table S1. The profiles 
of selected genes were sorted by arctan2 values, as provided in the 
table.
TCGA tumor samples TCGA normal samples
TCGA-A7-A13E-01A-11R-A12P-07 TCGA-A7-A13E-11A-61R-A12P-07
TCGA-A7-A13F-01A-11R-A12P-07 TCGA-A7-A13F-11A-42R-A12P-07
TCGA-BH-A0AU-01A-11R-A12P-07 TCGA-BH-A0AU-11A-11R-A12P-07
TCGA-BH-A0B5-01A-11R-A12P-07 TCGA-BH-A0B5-11A-23R-A12P-07
TCGA-BH-A0BS-01A-11R-A12P-07 TCGA-BH-A0BS-11A-11R-A12P-07
TCGA-BH-A0BZ-01A-31R-A12P-07 TCGA-BH-A0BZ-11A-61R-A12P-07
TCGA-BH-A0C3-01A-21R-A12P-07 TCGA-BH-A0C3-11A-23R-A12P-07
TCGA-BH-A0DD-01A-31R-A12P-07 TCGA-BH-A0DD-11A-23R-A12P-07
TCGA-BH-A0DT-01A-21R-A12D-07 TCGA-BH-A0DT-11A-12R-A12D-07
TCGA-BH-A0HA-01A-11R-A12P-07 TCGA-BH-A0HA-11A-31R-A12P-07
TCGA-BH-A18J-01A-11R-A12D-07 TCGA-BH-A18J-11A-31R-A12D-07
TCGA-BH-A18K-01A-11R-A12D-07 TCGA-BH-A18K-11A-13R-A12D-07
TCGA-BH-A18L-01A-32R-A12D-07 TCGA-BH-A18L-11A-42R-A12D-07
TCGA-BH-A18M-01A-11R-A12D-07 TCGA-BH-A18M-11A-33R-A12D-07
TCGA-BH-A18N-01A-11R-A12D-07 TCGA-BH-A18N-11A-43R-A12D-07
TCGA-BH-A18P-01A-11R-A12D-07 TCGA-BH-A18P-11A-43R-A12D-07
TCGA-BH-A18Q-01A-12R-A12D-07 TCGA-BH-A18Q-11A-34R-A12D-07
TCGA-BH-A18R-01A-11R-A12D-07 TCGA-BH-A18R-11A-42R-A12D-07
TCGA-BH-A18S-01A-11R-A12D-07 TCGA-BH-A18S-11A-43R-A12D-07
TCGA-BH-A18U-01A-21R-A12D-07 TCGA-BH-A18U-11A-23R-A12D-07
TCGA-BH-A18V-01A-11R-A12D-07 TCGA-BH-A18V-11A-52R-A12D-07
TCGA-BH-A1EO-01A-11R-A137-07 TCGA-BH-A1EO-11A-31R-A137-07
TCGA-BH-A1EU-01A-11R-A137-07 TCGA-BH-A1EU-11A-23R-A137-07
TCGA-E2-A153-01A-12R-A12D-07 TCGA-E2-A153-11A-31R-A12D-07
TCGA-E2-A158-01A-11R-A12D-07 TCGA-E2-A158-11A-22R-A12D-07
TCGA-E2-A15I-01A-21R-A137-07 TCGA-E2-A15I-11A-32R-A137-07
TCGA-E2-A15M-01A-11R-A12D-07 TCGA-E2-A15M-11A-22R-A12D-07
TCGA-E2-A1BC-01A-11R-A12P-07 TCGA-E2-A1BC-11A-32R-A12P-07
TABLE 1: TCGA samples.
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